Literature DB >> 3891617

Captopril potentiates chronotropic baroreflex responses to carotid stimuli in humans.

T J Ebert.   

Abstract

Angiotensin II is a potent vasoconstrictor and has profound effects on autonomic neural mechanisms in experimental animals. Human carotid baroreflex control of arterial pressure and heart period was examined before and after acutely decreasing angiotensin II levels by administering 50 mg of oral captopril, an angiotensin converting enzyme inhibitor. Carotid baroreceptor stimuli were delivered by a neck chamber worn by 14 normotensive volunteers. Four subjects received placebo. Arterial pressure responses to carotid distention and tachycardia in response to carotid compression were not changed in captopril or placebo groups; however, there was an augmented bradycardic response to carotid stretch in captopril-treated subjects. These results indicate that captopril has an asymmetrical effect on carotid baroreflex function and suggest that enhanced baroreflex mediated bradycardia is due to a reduction in central nervous system angiotensin II levels by captopril, which augments vagal-cardiac responses to carotid stimuli.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891617     DOI: 10.1161/01.hyp.7.4.602

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

Review 1.  Carotid baroreflex testing using the neck collar device.

Authors:  Victoria L Cooper; Roger Hainsworth
Journal:  Clin Auton Res       Date:  2009-02-19       Impact factor: 4.435

Review 2.  Importance of the renin-angiotensin-aldosterone system (RAS) in the physiology and pathology of hypertension. An overview.

Authors:  C M Ferrario
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  Carotid artery stenosis exposed by an adverse effect of captopril.

Authors:  H Jensen; H Ring-Larsen; P Garsdal; P Fruergaard
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

4.  Effects of single doses of quinapril and atenolol on autonomic nervous function and exercise capacity in healthy volunteers.

Authors:  I Pörsti; P Arvola; P Säynävälammi; A K Nurmi; T Metsä-Ketelä; K Koskenvuo; L A Laitinen; V Manninen; H Vapaatalo
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Vasopressin reduces cardiac function and augments cardiopulmonary baroreflex resistance increases in man.

Authors:  T J Ebert; A W Cowley; M Skelton
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

6.  The effect of acute and chronic captopril therapy on baroreflex function in man.

Authors:  G B Kondowe; A H Deering; J G Riddell; G D Johnston; D W Harron
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

7.  Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure.

Authors:  K J Osterziel; D Hänlein; R Willenbrock; C Eichhorn; F Luft; R Dietz
Journal:  Br Heart J       Date:  1995-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.